Fig. 2
From: The targets of aspirin in bladder cancer: bioinformatics analysis
Analysis of genetic alterations of 3 DPTs of aspirin (CCND1, MYC and TP53) in human bladder cancer studies embedded in cBio cancer genomics portal. A Overview of the changes in CCND1, MYC and TP53 in genomics datasets available in 3 different studies. B Visual summary of mutations across a set of human bladder cancer samples based on a query of the 3 genes in OncoPrint. Distinct genomic alterations including mutations, copy number alterations, exemplified by gene amplifications and homozygous deletions, are summarized and color coded (as % changes) in the affected genes in individual tumor samples. Each row represents a gene, and each column represents a tumor sample